Tackling the UK's pharma skills shortage

Ambitions are soaring for the UK’s pharma and biotech industry on the back of record investment but can it be sustained in the absence of workers with critical STEM skills? MHA’s Yogan Patel looks at strategies for attracting and retaining talent in an Expert View piece.

Last year saw record investment in the UK’s pharma and biotech sectors, estimated to be a 60% increase on the back of the country’s success in sequencing the COVID genome, developing vaccines, and expediting clinical trials.

Life science is expected to remain a growth industry across the coming decade, fueled further by the government’s aim of becoming a world leader in disease research, and accelerating the development of new treatments, medical technology and digital tools.